A study by Zhao et al. (2019) demonstrated that administration of resveratrol (10 mg/kg/day) to mice with transplanted cervical cancer cells (HeLa) significantly reduced tumour weight, an effect associated with modulation of the phospholipid scramblase 1 (PLSCR1) pathway [103]. This evidence concerns the gene PLSCR1 and cervical carcinoma.